Active immunotherapy.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D001886:Bordetella pertussis / Q000276:immunology; D003352:Corynebacterium / Q000276:immunology; D006801:Humans; D007114:Immunization; D007939:Leukemia L1210 / Q000188:drug therapy / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000628:therapy; D007962:Leukocytes / Q000276:immunology; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D009858:Oncogenic Viruses / Q000276:immunology; D011070:Poly I-C / Q000627:therapeutic use; D011119:Polynucleotides / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D015054:Zymosan / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000941:Antigens; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D011119:Polynucleotides; D015054:Zymosan; D011070:Poly I-C